In several clinical studies, adult and adolescent patients with active TB have been shown to harbor robustly higher cytolytic and IL-17-producing γδ T cells compared with healthy controls (369–371) (Figure 2), and this expansion decreases with TB drug treatment (362). Here, IL17A is linked to tuberculosis.